ABOS stock

Acumen Pharmaceuticals Inc (ABOS) financials · $73.3M cap

Acumen Pharmaceuticals Inc (ABOS) $73.3M cap.

Cached annual income statement
LineFY2025FY2024
Revenue$0$0
Cost of Revenue$0$0
Gross Profit$0$0
Operating Income-$123.8M-$114.0M
Net Income-$121.3M-$102.3M
EPS (Diluted)$-2.00$-1.71
Cached annual balance sheet
LineFY2025FY2024
Total Assets$122.8M$239.0M
Current Assets$122.3M$178.3M
Cash & Equivalents$54.0M$35.6M
Inventory$0$0
PP&E$103.0K$73.0K
Total Liabilities$52.4M$57.2M
Current Liabilities$30.0M$27.6M
Short-term Debt$8.8M$0
Long-term Debt$22.4M$29.4M
Total Debt$0$0
Shareholders' Equity$70.4M$181.8M
Retained Earnings-$446.5M-$325.1M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$115.5M-$86.2M
CapEx$88.0K$16.0K
Investing Cash Flow$133.9M$48.0M
Financing Cash Flow-$34.0K$6.9M
Dividends Paid$0$0
Net Change in Cash$0$0
Free Cash Flow-$115.6M-$86.2M

FAQ

What is ABOS P/E and revenue?

Acumen Pharmaceuticals Inc (ABOS) $73.3M cap.

What is ABOS revenue?

Acumen Pharmaceuticals Inc last cached revenue is $0 (FY2025).

Is ABOS profitable?

Acumen Pharmaceuticals Inc last cached net income is -$121.3M.

What are ABOS total assets?

Acumen Pharmaceuticals Inc last cached total assets are $122.8M.

What is ABOS free cash flow?

Acumen Pharmaceuticals Inc last cached free cash flow is -$115.6M.

Not investment advice. Cached statements, not a live tape.